AgingResearch.NewsJoin free

Allogeneic hematopoietic stem cell transplant

Allogeneic hematopoietic stem cell transplant has been studied in 1 paper since 2018: 1 observational study in people. The newest paper, Jul 1, 2018: “Clinical Correlates and Treatment Outcomes for Patients With Short Telomere Syndromes”.

Intervention

1 paper studies it1 findingUpdated

See all 1

“allogeneic hematopoietic stem cell transplant for progressive bone marrow failure (n=2), with 1 patient dying from transplant-related complications”
Clinical Correlates and Treatment Outcomes for Patients With Short Telomere SyndromesMayo Clinic proceedings2018doi:10.1016/j.mayocp.2018.05.015

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: National Center for Advancing Translational Sciences and 1 more
  • Humans1

What is Allogeneic hematopoietic stem cell transplant linked with?

1

Studies link Allogeneic hematopoietic stem cell transplant with 1 measure, most often transplant-related death (1 study).

Transplant-related death

upin humans1

1 study

  1. Allogeneic hematopoietic stem cell transplant is associated with transplant-related death in humans (for progressive bone marrow failure) (1 of 2 patients).

    “allogeneic hematopoietic stem cell transplant for progressive bone marrow failure (n=2), with 1 patient dying from transplant-related complications”

    Humansfor progressive bone marrow failuren = 2

    Clinical Correlates and Treatment Outcomes for Patients With Short Telomere Syndromes

    Mayo Clinic proceedings

Trial sponsors

Latest

Related